Human BTLA (31-150) (M105V, G138S, V148M) Protein, His Tag (MALS verified), Unconjugated

Artikelnummer: ABS-BTA-H52H5-50UG
Artikelname: Human BTLA (31-150) (M105V, G138S, V148M) Protein, His Tag (MALS verified), Unconjugated
Artikelnummer: ABS-BTA-H52H5-50UG
Hersteller Artikelnummer: BTA-H52H5-50ug
Alternativnummer: ABS-BTA-H52H5-50UG
Hersteller: AcroBiosystems
Wirt: Human
Kategorie: Proteine/Peptide
Spezies Reaktivität: Human
Konjugation: Unconjugated
B and Tlymphocyte attenuator (BTLA) is also known as B and Tlymphocyteassociated protein, CD antigen CD272. BTLA contains one Iglike Vtype (immunoglobulinlike) domain. As a lymphocyte inhibitory receptor, BTLA / CD272 inhibits lymphocytes during immune response. BTLA / CD272 can interact with tyrosine phosphatases PTPN6/SHP1 and PTPN11/SHP2, and interact with TNFRSF14/HVEM. - Proteine/Peptide
Molekulargewicht: 15.8 kDa
Tag: C-10*His
NCBI: 44003
Puffer: PBS, pH7.4
Reinheit: 90%
Formulierung: Powder
Target-Kategorie: BTLA
Immobilized Human BTLA (31-150) (M105V, G138S, V148M), His Tag (Cat. No. BTA-H52H5) at 5 µg/mL (100 µL/well) can bind Human HVEM, Fc Tag (Cat. No. HVM-H5258) with a linear range of 0.6-5 ng/mL (QC tested).
Immobilized Human BTLA (31-150) (M105V, G138S, V148M), His Tag (Cat. No. BTA-H52H5) at 5 µg/mL (100 µL/well) can bind Human HVEM, Mouse IgG2a Fc Tag, low endotoxin with a linear range of 0.6-39 ng/mL (Routinely tested).
BTA-H52H5-50ug
Human BTLA (31-150) (M105V, G138S, V148M), His Tag on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 90%.